Yes, we do know about this, and we've undertaken further analysis to look into these numbers. In our system right now, we use some of the analysis that Mr. Campbell mentioned earlier to identify our high-risk cases. We look at the number of prescriptions and the number of doctors and we do that analysis. We follow up with pharmacists and doctors--